These findings underscore the clinical significance of the CDK1-USP33-SIN1 axis, suggesting that it may serve as a potential therapeutic target for regulating tumor growth and chemosensitivity in PDAC (Fig. 6c). The gene discussed is MAPKAP1; the disease is neoplasm.